Genomictree Inc. (228760) — Capital Reinvestment Ratio
Genomictree Inc. (228760) has a Capital Reinvestment Ratio of 0.43x as of December 2022, meaning it reinvests 0% of its operating cash flow (₩4.29 Billion) in capital expenditures (₩1.82 Billion). Check tangible equity quality of Genomictree Inc. to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Genomictree Inc. Capital Reinvestment Ratio (2022–2022)
This chart tracks Genomictree Inc.'s Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see 228760 operating cash flow.
Annual Capital Reinvestment Ratio for Genomictree Inc. (2022–2022)
Year-by-year Capital Reinvestment Ratio for Genomictree Inc. from 2022 to 2022. See free cash flow generation of Genomictree Inc. to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.43x | ₩4.29 Billion | ₩1.82 Billion | — |